Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib

(MedPage Today) -- Adding a targeted agent to second-line chemotherapy significantly improved progression-free survival (PFS) but not overall survival (OS) in advanced gastric cancer, a large randomized trial showed. Pairing the angiogenesis inhibitor...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news